Clinical outcomes of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis of global data

C Xu, Z Yi, R Cai, R Chen, BYH Thong, R Mu - Autoimmunity reviews, 2021 - Elsevier
Objectives The impact of rheumatic diseases on COVID-19 infection remains poorly
investigated. Here we performed a systematic review and meta-analysis to evaluate the …

[PDF][PDF] SARS-CoV-2 infection in patients with systemic autoimmune diseases

P Brito-Zerón, A Sisó-Almirall… - Clin Exp …, 2021 - clinexprheumatol.org
Systemic autoimmune diseases (SAD) are a heterogeneous group of diseases with a
common aetiopathogenic basis affecting all ages characterised by a systemic phenotypic …

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a …

SE Sattui, R Conway, MS Putman, AM Seet… - The Lancet …, 2021 - thelancet.com
Background Patients with primary systemic vasculitis or polymyalgia rheumatica might be at
a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ …

The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome

G Ozcifci, T Aydin, Z Atli, II Balkan, F Tabak… - Rheumatology …, 2022 - Springer
Initial case series of small number of patients at the beginning of the pandemic reported a
rather guarded prognosis for Behçet's syndrome (BS) patients infected with SARS-CoV-2. In …

Coronavirus disease 2019 in patients with Behcet's disease: a report of 59 cases in Iran

F Shahram, K Esalatmanesh, A Khabbazi… - Clinical …, 2022 - Springer
Objectives To present the clinical characteristics, disease course, management, and
outcomes of COVID-19 infection in patients with Behcet's disease (BD). Methods In this …

[PDF][PDF] One year in review 2021: Behçet's syndrome

G Hatemi, E Seyahi, I Fresko, R Talarico… - Clin Exp …, 2021 - clinexprheumatol.org
This review aims to provide a critical digest of the recent studies that enhance our
understanding of Behçet's syndrome by evaluating time trends, differences in disease …

COVID-19 in patients with Behçet's disease: Outcomes and rate of Behçet's exacerbations in a retrospective cohort

B Polat, A Erden, SC Güven, B Armağan… - Modern …, 2022 - academic.oup.com
Objectives The aim of this study is to investigate the outcomes of coronavirus disease 2019
(COVID-19) in our cohort of Behçet's disease (BD) patients and to reveal the rate of BD …

[HTML][HTML] Adamantiades‐Behçet's disease (Behçet's disease) and COVID‐19

CC Zouboulis, JAM Van Laar, M Schirmer… - Journal of the …, 2021 - ncbi.nlm.nih.gov
1 Galván Casas C, Catala A, Carretero Hernández G et al. Classification of the cutaneous
manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with …

Clinical course of Covid-19 in a cohort of patients with Behçet disease

M Correa-Rodríguez, JL Callejas-Rubio… - Medicina Clínica, 2022 - Elsevier
Abstract Objective The implications of Covid-19 in patients with Behçet's disease (BD) are
unknown. Patients with BD usually take long-term therapy with therapeutic agents that have …

[PDF][PDF] Prevalence and clinical course of SARS-CoV-2 infection in patients with Behçet's syndrome

I Mattioli, A Bettiol, E Silvestri, ML Urban… - Clin Exp …, 2021 - clinexprheumatol.org
Objective. We aimed to assess the prevalence of SARS-CoV-2 infection among Behçet's
syndrome (BS) patients, evaluating the possible association between demographic and …